Aerosolized amphotericin B-liposomes for treatment of systemic Candida infections in mice

B. E. Gilbert, P. R. Wyde, G. Lopez-Berestein, S. Z. Wilson

Research output: Contribution to journalComment/debatepeer-review

25 Scopus citations

Abstract

Mice lethally infected with Candida albicans were exposed to small- particle aerosols containing amphotericin B-liposomes. The drug, when administered twice daily for 2 h (0.58 mg/kg of body weight per day) on days 1, 2, and 3 postinoculation, significantly reduced the numbers of Candida organisms in the kidneys. Aerosol treatment increased the survival time of mice given 2 2-h treatments once a week for 4 weeks. A twice-weekly, 2-h small-particle aerosol administration of amphotericin B-liposomes for 1, 2, or 3 weeks significantly increased both the mean time of survival and percent survival.

Original languageEnglish (US)
Pages (from-to)356-359
Number of pages4
JournalAntimicrobial agents and chemotherapy
Volume38
Issue number2
DOIs
StatePublished - 1994

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)
  • Infectious Diseases

Fingerprint

Dive into the research topics of 'Aerosolized amphotericin B-liposomes for treatment of systemic Candida infections in mice'. Together they form a unique fingerprint.

Cite this